Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04999644 · ClinicalTrials.gov registry record · Early Phase 1
Reduced Nicotine Cigarette Purchasing Decisions
A Early Phase 1 study of Tobacco Use Disorder, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04999644: Completed Early Phase 1 study of Tobacco Use Disorder, sponsored by Johns Hopkins University.
NCT04999644 is a Early Phase 1 study of Tobacco Use Disorder that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04999644, a Early Phase 1 study of Tobacco Use Disorder, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.
Primary Outcome
Consumption of cigarettes at unconstrained price as measured by an incentivized demand task. Minimum value is 0, maximum value is not constrained. Higher scores indicate more cigarette consumption at unconstrained price (a worse outcome).
Conditions Studied
Interventions
- DRUG Full Nicotine Cigarettes
- DRUG Reduced Nicotine Cigarettes
- BEHAVIORAL Average Nicotine Expectancy
- BEHAVIORAL Very Low Nicotine Expectancy
Study Locations (1)
Maryland
- Behavioral Pharmacology Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2023-03-29 |
| Phase | Early Phase 1 |
What the finished NCT04999644 record still lists
NCT04999644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Full Nicotine Cigarettes is the first listed.
NCT04999644 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04999644 about?
NCT04999644 is a clinical study titled "Reduced Nicotine Cigarette Purchasing Decisions". The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.
What is the current status of trial NCT04999644?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2022-02-23. Estimated completion is 2023-03-29.
What conditions does trial NCT04999644 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT04999644?
The interventions under investigation include: Full Nicotine Cigarettes (DRUG), Reduced Nicotine Cigarettes (DRUG), Average Nicotine Expectancy (BEHAVIORAL), Very Low Nicotine Expectancy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04999644?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04999644 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04999644's enrollment target sits among peer trials
21 67th of 70 higher than 4 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
Cannabis-Tobacco Co-Use Treatment Study
RECRUITING · Phase 3
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI